Tuesday, 18 September 2018
BioLargo Spotlight: BioLargo's Newly Redesigned Website!
Today we launched BioLargo’s updated website! Replacing the company’s original (and sorely outdated) website, the new page uses modern web design tools and assets, making it a huge aesthetic and functional upgrade. You can find the website at the same URL –. We encourage our followers and shareholders to explore the new site and see the improvements for themselves.
We are very excited about the new site, as it represents a big improvement to the company’s digital presence. BioLargo is a fast-moving and dynamic company with many high growth potential assets and business units, and its online presence must be of a standard befitting our exciting and important portfolio. We think this new website represents a significant step toward that goal.
You can comment on our new website on Twitter at– we’d love to hear from you!
What is a BioLargo Spotlight?
It’s an exciting time at BioLargo. We’re moving fast, and it can be difficult to keep our stockholders and the investing public informed of our progress. In light of this, we will be posting a series of short articles titled “BioLargo Spotlight”, highlighting certain business activities and other important information in between our required SEC filings. Of course, these do not replace our public filings, which contain more complete information than can be delivered in this forum, and thus we urge you to carefully read and rely on those filings for definitive information, and to review our risk factors and caution regarding forward-looking statements. We are optimistic about our business as we work hard to continue to grow and ultimately generate profits for our stockholders.
Our attorneys remind us that while we believe these developments are important and that these small victories could add up and lead to big victories, at this stage they do not rise to the level of an official material disclosure. As the size and magnitude of these developments become material, we will naturally report that information in an 8-K and our regular SEC filings.